Misoprostol: Off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy);Misoprostol: utilisation hors AMM au premier trimestre de la grossesse (fausses couches spontanées, interruptions médicales et volontaires de grossesse)

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 43, Issue 2, 2014, Pages 123-145

  Beucher, G ^a   Dolley, P ^a,c   Carles, G ^b   Salaun, F ^a   Asselin, I ^a   Dreyfus, M ^a,c  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b Centre hospitalier de l'Ouest Guyanais   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

Cervical ripening; Chirurgical uterine evacuation; Early miscarriage; Early pregnancy failure; Medical abortion; Misoprostol; Termination of pregnancy

Indexed keywords

ASPIRATION UTÉRINE; CERVICAL RIPENING; CHIRURGICAL UTERINE EVACUATION; EARLY MISCARRIAGE; EARLY PREGNANCY FAILURE; ÉCHEC PRÉCOCE DE GROSSESSE; FAUSSE COUCHE SPONTANÉE PRÉCOCE; INTERRUPTION MÉDICALE DE GROSSESSE; MEDICAL ABORTION; MISOPROSTOL; PRÉPARATION CERVICALE; TERMINATION OF PREGNANCY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, BUCCAL; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, SUBLINGUAL; CERVICAL RIPENING; FEMALE; FRANCE; HUMANS; MISOPROSTOL; OFF-LABEL USE; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 84894446194     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2013.11.007     Document Type: Article

References (95)

1. N. Kapp, P.A. Lohr, T.D. Ngo, and J.L. Hayes Cervical preparation for first trimester surgical abortion Cochrane Database Syst Rev 2 2010 CD007207
2. O. Meirik, N.T.M. Huong, G. Piaggio, E. Bergel, and H. von Hertzen Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicenter randomized trial Lancet 379 2012 1817 1824
3. D. Bartz, R. Maurer, R.H. Allen, J. Fortin, B. Kuang, and A.B. Goldberg Buccal misoprostol compared synthetic osmotic cervical dilator before surgical abortion: a randomized controlled trial Obstet Gynecol 122 2013 57 63
4. Royal College of Obstetricians and Gynaecologists The management of early pregnancy loss. RCOG guideline No. 25 2006 RCOG Press London
5. F. Blohm, B. Friden, and I. Milson A prospective longitudinal population-based study of clinical miscarriage in an urban Swedish population BJOG 115 2008 176 182
6. G. Beucher, G. Benoist, and M. Dreyfus Prise en charge des fausses couches spontanées du premier trimestre Gynecol Obstet Fertil 37 2009 257 264
7. G. Beucher, T. Beillat, and M. Dreyfus Prise en charge des fausses couches spontanées du premier trimestre J Gynecol Obstet Biol Reprod 32 2003 5 21
8. B.A. Chen, and M.D. Creinin Contemporary management of early pregnancy failure Clin Obstet Gynecol 50 2007 67 88
9. NICE Clinical Guideline Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage. National Collaborating Centre for Women's and Children's Health 2012 RCOG London
10. J.F. Brouns, M.P. Burger, and W.J. van Wijngaarden Evaluation of the introduction of a new treatment for te termination of pregnancy in the Netherlands Acta Obstet Gynecol Scand 89 2010 1210 1213
11. R.G. Farquharson, E. Jauniaux, and N. Exalto ESHRE Special Interest Group for Early Pregnancy (SIGEP). Updated and revised nomenclature for description of early pregnancy events Hum Reprod 20 2005 3008 3011
12. L. Morin, and M.C. Van den Hof Society of Obstetricians and Gynaecologists of Canada. Directives cliniques de la SOGC. Évaluation échographique des complications liées à la grossesse pendant le premier trimestre J Obstet Gynaecol Can 27 2005 586 591
13. W.M. Ankum, M. Wieringa-DeWaard, and P.J.E. Bindels Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice BMJ 322 2001 1343 1346
14. E. Jauniaux, J. Johns, and G.J. Burton The role of ultrasound imaging in diagnosing and investigating early pregnancy failure Ultrasound Obstet Gynecol 25 2005 613 624
15. E. Sawyer, and D. Jurkovic Ultrasonography in the diagnosis and management of abnormal early pregnancy Clin Obstet Gynecol 50 2007 31 54
16. G. Condous, E. Okaro, and T. Bourne The conservative management of early pregnancy complications: a review of the literature Ultrasound Obstet Gynecol 2003 420 430
17. E. Sawyer, E. Ofuasia, D. Ofili-Yebovi, S. Helmy, J. Gonzalez, and D. Jurkovic The value of measuring endometrial thickness and volume on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage Ultrasound Obstet Gynecol 29 2007 205 209
18. M.F. Reeves, P.A. Lohr, B.J. Harwood, and M.D. Creinin Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure Obstet Gynecol 111 2008 106 112
19. J. Trinder, P. Brocklehurst, R. Porter, M. Read, S. Vyas, and L. Smith Management of miscarriage: expectant, medical or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial) BMJ 332 2006 1235 1240
20. J. Zhang, J.M. Gilles, K. Barnhart, M.D. Creinin, C. Westhoff, and M.M. Frederick A comparison of medical management with misoprostol and surgical management for early pregnancy failure N Engl J Med 353 2005 761 769
21. G.C.M. Graziosi, B.W. Mol, W.M. Ankum, and H.W. Bruinse Management of early pregnancy loss Int J Gynecol Obstet 86 2004 337 346
22. J.P. Neilson, M. Hickey, and J. Vazquez Medical treatment for early fetal death (less than 24 weeks) Cochrane Database Syst Rev 3 2006 CD002253
23. A. Sotiriadis, G. Makrydimas, S. Papatheodorou, and J.P.A. Ioannidis Expectant, medical or surgical management of first-trimester miscarriage: a meta-analysis Obstet Gynecol 105 2005 1104 1113
24. D. Yu, Y.M. Wong, Y. Cheong, E. Xia, and T.C. Li Asherman syndrome-one century later Fertil Steril 89 2008 759 779
25. I.C.D. Westendorp, W.M. Ankum, B.W.J. Mol, and J. Vonk Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion Hum Reprod 13 1998 3347 3350
26. K. Gemzell-Danielsson, P.C. Ho, R. Gomez Ponce de Leon, A. Weeks, and B. Winikoff Misoprostol to treat missed abortion in the first trimester Int J Gynecol Obstet 99 2007 S182 S185
27. O.S. Tang, K. Gemzell-Danielsson, and P.C. Ho Misoprostol: pharmacokinetic profiles effects on the uterus and side-effects Int J Gynecol Obstet 99 2007 S160 S167
28. G. Beucher, S. Baume, Y. Bekkari, M. Legrand-Horras, M. Herlicoviez, and M. Dreyfus Traitement médical des fausses couches spontanées précoces: étude prospective d'une prise en charge ambulatoire à l'aide du misoprostol J Gynecol Obstet Biol Reprod 33 2004 401 406
29. O.S. Tang, W.N.T. Lau, E.H.Y. Ng, S.W.H. Lee, and P.C. Ho A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage Hum Reprod 18 2003 176 181
30. O.S. Tang, C.Y. Ong, K.Y. Tse, E.H. Ng, S.W. Lee, and P.C. Ho A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage Hum Reprod 21 2006 189 192
31. F. Barceló, C. De Paco, J.J. López-Espín, Y. Silva, L. Abad, and J.J. Parrilla The management of missed miscarriage in an outpatient setting: 800 versus 600 μg of vaginal misoprostol Aust N Z Obstet Gynaecol 12 2012 39 43
32. M.D. Creinin, X. Huang, C. Westhoff, K. Barnhart, J.M. Gilles, and J. Zhang Factors related to successful misoprostol treatment for early pregnancy failure Obstet Gynecol 107 2006 901 907
33. C. Robledo, J. Zhang, J. Troendle, K. Barnhart, M.D. Creinin, and C. Westhoff et al. Clinical indicators for success of misoprostol treatment after early pregnancy failure Int J Gynaecol Obstet 99 2007 46 51
34. A. Torre, C. Huchon, L. Bussieres, E. Machevin, E. Camus, and A. Fauconnier Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial Am J Obstet Gynecol 206 2013 215 [e1-6]
35. M. Fischer, J. Bhatnagar, J. Guarner, S. Reagan, J.K. Hacker, and S.H. Van Meter et al. Fatal shock syndrome associated with Clostridium sordellii after medical abortion N Engl J Med 353 2005 2352 2360
36. C. Lamy, C. Mezan de Malartic, E. Perdriolle, E. Gauchotte, S. Villeroy-de-Galhau, and M.O. Delaporte et al. Prise en charge des infections du post-abortum J Gynecol Obstet Biol Reprod 41 2012 904 912
37. G.W. Kong, I.H. Lok, A.K. Yiu, A.S. Hui, B.P. Lai, and T.K. Chung Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage-a randomised controlled trial Aust N Z J Obstet Gynaecol 53 2013 170 177
38. B.A. Chen, M.F. Reeves, M.D. Creinin, J.M. Gilles, K. Barnhart, and C.W. Westhoff et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery Am J Obstet Gynecol 198 2008 626 [e1-5]
39. J.H.S. You, and T.K.H. Chung Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis Hum Reprod 20 2005 2873 2878
40. M. Rausch, S. Lorch, K. Chung, M. Frederick, J. Zhang, and K. Barnhart A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss Fertil Steril 97 2012 355 360
41. G.C. Graziosi, J.W. van der Steeg, P.H. Reuwer, A.P. Drogtrop, H.W. Bruinse, and B.W. Mol Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management Hum Reprod 20 2005 1067 1071
42. C. Luise, K. Jermy, C. May, G. Costello, W.P. Collins, and T.H. Bourne Outcome of expectant management of spontaneous first trimester miscarriage: obsvervational study BMJ 324 2002 873 875
43. K. Nanda, L.M. Lopez, D.A. Grimes, A. Peloggia, and G. Nanda Expectant care versus surgical treatment for miscarriage Cochrane Database Syst Rev 3 2012 CD003518
44. L.F.P. Smith, P.D. Ewings, and C. Quinlan Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long-term follow-up of miscarriage treatment (MIST) randomised controlled trial BMJ 339 2009 b3827
45. A. Reynolds, D. Ayres-de-Campos, M.A. Costa, and N. Montenegro How should success be defined when attempting medical resolution of first-trimester missed abortion? Eur J Obstet Gynecol Reprod Biol 118 2005 71 76
46. M.A. Verschoor, M. Lemmers, P.M. Bossuyt, G.C. Graziosi, P.J. Hajenius, and D.J. Hendriks et al. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial BMC Pregnancy Childbirth 13 2013 102
47. J.P. Neilson, G.M. Gyte, M. Hickey, Vazquez, and L. Dou Medical treatments for incomplete miscarriage (less than 24 weeks) Cochrane Database Syst Rev 3 2013 CD007223
48. O. Tunçalp, A.M. Gulmezoglu, and J.P. Souza Surgical procedures to evacuating incomplete abortion Cochrane Database Syst Rev 9 2010 CD001993
49. H. Hamoda, and A. Templeton Medical and surgical options for induced abortion in first trimester Best Pract Res Clin Obstst Gynaecol 24 2010 503 516
50. E. Raymond, C. Shannon, M. Weaver, and B. Winikoff First trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review Contraception 87 2013 26 37
51. R. Kulier, N. Kapp, A.M. Gülmezoglu, G.J. Hofmeyr, L. Cheng, and A. Campana Medical methods for first trimester abortion Cochrane Database Syst Rev 11 2011 CD002855
52. E. Wiebe, S. Dunn, E. Guilbert, F. Jacot, and L. Lugtig Comparison of abortion induced by methotrexate or mifepristone followed by misoprostol Obstet Gynecol 99 2002 813 819
53. Haute Autorité de santé. Interruption volontaire de grossesse par méthode médicamenteuse. Recommandations de bonne pratique. Décembre 2010. www.has-sante.fr/publications.
54. P.F. Svendsen, C. Rrbye, T. Vejborg, and L. Nilas Comparison of gemeprost and vaginal misoprostol in first trimester mifepristone-induced abortion Contraception 72 2005 28 32
55. J. Tang, N. Kapp, M. Dragoman, and J.P. de Souza WHO recommendations for misoprostol use for obstetric and gynecologic indications Int J Gynecol Obstet 121 2013 186 189
56. World Health Organization Safe abortion: technical and policy guidance for health systems 2nd ed 2012 World Health Organization Geneva
57. A. Faundes FIGO Guidelines. The combination of mifepristone for the termination of pregnancy Int J Gynecol Obstet 115 2011 1 4
58. World Health Organization. WHO Essential Medicines Library. www.who.int/reproductivehealth/publications.
59. L. Say, R. Kulier, M. Gülmezoglu, and A. Campana Medical versus surgical methods for first trimester termination of pregnancy Cochrane Database Syst Rev 25 2005 CD003037
60. R.C. Henshaw, S.A. Naji, I.T. Russel, and A.A. Templeton A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae Hum Reprod 9 1994 2167 2172
61. C. Rorbye, M. Norgaard, and L. Nilas Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study Contraception 70 2004 393 399
62. P.W. Ashok, A. Kidd, G.M. Flett, A. Fitzmaurice, W. Graham, and A. Templeton A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation Hum Reprod 17 2002 92 98
63. H. Honkanen, G. Piaggio, H. Hertzen, G. Bartfai, R. Erdenetungalag, and K. Gemzell-Danielsson et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion BJOG 111 2004 715 725
64. J. Wen, Q.Y. Cai, F. Deng, and Y.P. Li Manual versus electric vacuum aspiration for first-trimester abortion: a systematic review BJOG 115 2008 5 13
65. R. Kulier, A. Fekih, G.J. Hofmeyr, and A. Campana Surgical methods for first trimester termination pregnancy Cochrane Database Syst Rev 4 2001 CD002900
66. Royal College of Obstetricians and Gynaecologists The care of women requesting induced abortion: evidence-based clinical guideline number 7 2011 RCOG Press London
67. H. von Hertzen, G. Piaggio, D. Wojdyla, L. Marions, N.T. My Huong, and O.S. Tang et al. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomized factorial controlled equivalence trial BJOG 116 2009 381 389
68. M.L. Swahn, and M. Bygdeman The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin Br J Obstet Gynecol 95 1988 126 134
69. E. Schaff Evidence of shortening the time interval of prostaglandin after mifepristone for medical abortion Contraception 74 2006 42 44
70. L. Wedisinghe, and D. Elsandabesee Flexible mifepristone and misoprostol administration interval for first-trimester medical termination Contraception 81 2010 269 274
71. M.D. Creinin, C.A. Schreiber, P. Bednarek, H. Lintu, M.S. Wagner, and L.A. Meyn et al. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial Obstet Gynecol 109 2007 885 894
72. K. Coyaji, U. Krishna, S. Ambardekar, H. Bracken, V. Raote, and A. Mandlekar et al. Are two doses of misoprostol after mifepristone for early abortion better than one? BJOG 114 2007 271 278
73. C. Shannon, E. Wiebe, F. Jacot, E. Guilbert, S. Dunn, and W. Sheldon et al. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial BJOG 113 2006 621 628
74. J. Bartley, A. Brown, R. Elton, and D.T. Baird Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation Hum Reprod 16 2001 2098 2102
75. H. El-Refaey, D. Rajasekar, M. Abdalla, L. Calder, and A. Templeton Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol N Engl J Med 332 1995 983 987
76. E.A. Schaff, S.L. Fielding, C. Westhoff, C. Ellertson, S.H. Eisinger, and L.S. Stadalius et al. Vaginal misoprostol administered 1, 2 or 3 days after mifepristone for early medical abortion JAMA 284 2000 1948 1953
77. H. von Hertzen, H. Honkanen, G. Piaggio, G. Bartfai, R. Erdenetungalag, and K. Gemzell-Danielsson et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: efficacy BJOG 110 2003 808 818
78. T. Middleton, E. Schaff, S.L. Fielding, M. Scahill, C. Shannon, and E. Westheimer et al. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period Contraception 72 2005 328 332
79. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation BJOG 112 2005 1102 1108
80. O.S. Tang, C.C. Chan, E.H. Ng, S.W. Lee, and P.C. Ho A prospective, randomized, placebo-of controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks of gestation Hum Reprod 18 2003 2315 2318
81. H. von Hertzen, N.T. Huong, G. Piaggio, M. Bayalag, E. Cabezas, and A.H. Fang et al. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial BJOG 117 2010 1186 1196
82. B. Winikoff, I.G. Dzuba, M.D. Creinin, W.A. Crowden, A.B. Goldberg, and J. Gonzales et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial Obstet Gynecol 112 2008 1303 1310
83. S. Raghavana, R. Comendant, I. Digol, S. Ungureanu, V. Friptu, and H. Bracken et al. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol Contraception 79 2009 84 90
84. J. Chai, C.Y. Wong, and P.C. Ho A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation Contraception 87 2013 480 485
85. S. Raghavan, R. Comendant, I. Digol, S. Ungureanus, I. Dondiuc, and S. Turcanu et al. Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial Contraception 82 2010 513 519
86. E. Chong, T. Tsereteli, N.N. Nguyen, and B. Winikoff A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion Contraception 86 2012 251 256
87. M.F. Gallo, S. Cahill, L. Castleman, and E.M. Mitchell More than one dose of misoprostol in medical abortion at less than ten weeks of gestation Contraception 74 2006 36 41
88. P.W. Ashok, A. Templeton, P.T. Wagaarachchi, and G.M. Flett Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases BJOG 109 2002 1281 1289
89. H. Hamoda, P.W. Ashok, G.M. Flett, and A. Templeton Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases Contraception 71 2005 327 332
90. M. Largeaud, W. El Guindi, F. Perotti, Y. Montoya, G. Carles, and B. Seve L'interruption volontaire de grossesse médicamenteuse de 9 à 14 semaines d'aménorrhée. Étude prospective de 105 cas à Saint-Laurent-du-Maroni (Guyane française) J Gynecol Obstet Biol Reprod 33 2004 119 124
91. O. Garbin, C. Vayssiere, K. Bettahar-Lebugle, and I. Nisand Consistency of medical abortion efficacy from 5 through 14 weeks' gestation Eur J Obstet Gynecol Reprod Biol 129 2006 36 40
92. Q. Chen, S. Hou, C. Meads, Y. Huang, Q. Hong, and H. Zhu et al. Mifepristone in combination with prostaglandines for termination of 10-16 weeks' gestation: a systematic review Eur J Obstet Gynecol reprod Biol 159 2011 247 254
93. P.W. Ashok, H. Hamoda, G.M. Flett, A. Kidd, A. Fitzmaurice, and A. Templeton Psychological sequelae of medical and surgical abortion at 10-13 weeks gestation Acta Obstet Gynecol Scand 84 2005 761 766
94. P. Slade, S. Heke, J. Fletcher, and P. Stewart A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care BJOG 105 1998 1288 1295
95. T.D. Ngo, M.H. Park, H. Shakur, and C. Free Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review Bull World Health Organ 89 2011 360 370